As of June 10, 2025, Cell Tech International Inc (EFLI) reports a ROA (Return on Assets) of -38.75%.
ROA (Return on Assets) evaluates how effectively a company turns its assets into profits, showcasing resource utilization.
Historical Trend of Cell Tech International Inc's ROA (Return on Assets)
Over recent years, Cell Tech International Inc's ROA (Return on Assets) has shown a stable trend. The table below summarizes the historical values:
| Date | ROA (Return on Assets) |
|---|---|
| 1997-12-31 | -38.75% |
| 1996-12-31 | -11.28% |
| 1995-12-31 | -56.57% |
This fluctuation highlights how Cell Tech International Inc manages its efficiency in using assets to generate earnings over time.
Comparing Cell Tech International Inc's ROA (Return on Assets) to Peers
To better understand Cell Tech International Inc's position, it's useful to compare its ROA (Return on Assets) against industry peers. Below are selected comparisons:
| Company | ROA (Return on Assets) |
|---|---|
| Cell Tech International Inc (EFLI) | -38.75% |
| PAVmed Inc (PAVM) | 129.78% |
| United American Healthcare Corp (UAHC) | 3.39% |
| Nexeon Medsystems Inc (NXNN) | -10.70% |
| Remedent Inc (REMI) | -11.43% |
| DiaSys Corp (DYXC) | -31.55% |
Compared to its competitors, Cell Tech International Inc's ROA (Return on Assets) is among the highest compared to peers, demonstrating superior efficiency in generating earnings from assets.